Therapeutic Area Specialist (TAS) - Oncology at Bristol-Myers Squibb

Canelones, Uruguay

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Advanced scientific degree
Preferred 5+ years of experience (inferred from incomplete "preferred 5&")

Responsibilities

Promotes approved indications of BMS oncology products within a defined territory or region to meet or exceed assigned sales targets in a compliant manner
Creates demand for BMS medicines by articulating in a balanced manner the clinical and scientific rationale for the use of products in appropriate patients
Engages with a high level of scientific expertise in all assigned products and therapeutic areas
Prepares and successfully implements comprehensive territory and account plans
Demonstrates scientific expertise and passion in using approved scientific resources and publications to present information to HCPs and ensures medical accuracy
Engages with HCPs to discuss product-related scientific information that is on and consistent with the label
Organizes and implements learning programs for healthcare professionals, facilitating scheduling and logistics according to IMC and BMS guiding principles
Maintains a high level of working expertise on emerging data for approved indications
Gathers and shares relevant insights and information internally with the appropriate stakeholders to enable BMS to better serve its customers
Complies with all laws, regulations, and policies that govern the conduct of BMS
Proactively collaborates with other teams and team members to ensure the best customer experience for HCPs

Skills

Oncology

HCP Engagement

Scientific Communication

Pharmaceutical Sales

Thought Leader Management

Medical Oncology

Demand Generation

KOL Engagement

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free